
Sign up to save your podcasts
Or


Sonal Gupta, MD, PhD, SVP and Head of Clinical Development at Affyimmune Therapeutics talks with host Emily Walsh Martin, PhD, to explore the challenges of cell therapy clinical trials and how to move patients quickly and thoughtfully through the steps required to receive therapy in aggressive solid tumor cancers.
But first, "we’ve moved straight from pumpkin spice season into ASGCT Annual Meeting registration season," as Dr. Walsh Martin says. So hop online and join ASGCT, then register and take advantage of the incredible member discounts on Annual Meeting registration. We’ll see you in New Orleans, May 13-17, 2025!
AnnualMeeting.ASGCT.org/register
Music by: https://www.steven-obrien.net/
--------------------------
Bright New Morning - Steven O'Brien
(Used for free under a Creative Commons Attribution 4.0 License: https://creativecommons.org/licenses/by/4.0/)
Show your support for ASGCT!: https://asgct.org/membership/donate
See omnystudio.com/listener for privacy information.
By American Society of Gene & Cell Therapy4.9
1616 ratings
Sonal Gupta, MD, PhD, SVP and Head of Clinical Development at Affyimmune Therapeutics talks with host Emily Walsh Martin, PhD, to explore the challenges of cell therapy clinical trials and how to move patients quickly and thoughtfully through the steps required to receive therapy in aggressive solid tumor cancers.
But first, "we’ve moved straight from pumpkin spice season into ASGCT Annual Meeting registration season," as Dr. Walsh Martin says. So hop online and join ASGCT, then register and take advantage of the incredible member discounts on Annual Meeting registration. We’ll see you in New Orleans, May 13-17, 2025!
AnnualMeeting.ASGCT.org/register
Music by: https://www.steven-obrien.net/
--------------------------
Bright New Morning - Steven O'Brien
(Used for free under a Creative Commons Attribution 4.0 License: https://creativecommons.org/licenses/by/4.0/)
Show your support for ASGCT!: https://asgct.org/membership/donate
See omnystudio.com/listener for privacy information.

43,898 Listeners

30,666 Listeners

43,528 Listeners

25,797 Listeners

766 Listeners

145 Listeners

821 Listeners

6,435 Listeners

111,948 Listeners

56,508 Listeners

337 Listeners

16,399 Listeners

6,381 Listeners

15,950 Listeners

38 Listeners